On Friday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) opened lower -0.71% from the last session, before settling in for the closing price of $7.04. Price fluctuations for RCKT have ranged from $4.55 to $26.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 15.41% at the time writing. With a float of $99.95 million, this company’s outstanding shares have now reached $106.75 million.
The firm has a total of 299 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rocket Pharmaceuticals Inc is 7.23%, while institutional ownership is 96.43%. The most recent insider transaction that took place on Apr 22 ’25, was worth 5,139. In this transaction an insider of this company sold 718 shares at a rate of $7.16, taking the stock ownership to the 65,039 shares. Before that another transaction happened on Apr 22 ’25, when Company’s Officer proposed sale 718 for $7.16, making the entire transaction worth $5,140.
Rocket Pharmaceuticals Inc (RCKT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 15.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.36% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Check out the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). In the past quarter, the stock posted a quick ratio of 9.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.63, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Analysing the last 5-days average volume posted by the [Rocket Pharmaceuticals Inc, RCKT], we can find that recorded value of 3.54 million was better than the volume posted last year of 2.27 million. As of the previous 9 days, the stock’s Stochastic %D was 34.15%. Additionally, its Average True Range was 0.61.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 27.73%, which indicates a significant decrease from 38.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.36% in the past 14 days, which was higher than the 84.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.36, while its 200-day Moving Average is $13.48. Now, the first resistance to watch is $7.24. This is followed by the second major resistance level at $7.50. The third major resistance level sits at $7.69. If the price goes on to break the first support level at $6.79, it is likely to go to the next support level at $6.60. Now, if the price goes above the second support level, the third support stands at $6.34.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
There are currently 106,786K shares outstanding in the company with a market cap of 746.46 million. Presently, the company’s annual sales total 0 K according to its annual income of -258,750 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -60,330 K.
